Influenza and SARS-CoV-2 combination vaccine (Metaclipse Therapeutics)

N/A

Report date: 2025/01/10 14:24:12

Base Information

Drug NameInfluenza and SARS-CoV-2 combination vaccine (Metaclipse Therapeutics)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetaclipse Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMetaclipse Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A